Skip to main content
Erschienen in: Indian Journal of Pediatrics 2/2018

16.06.2017 | Review Article

Advances Towards Painless Vaccination and Newer Modes of Vaccine Delivery

verfasst von: Neha Garg, Anju Aggarwal

Erschienen in: Indian Journal of Pediatrics | Ausgabe 2/2018

Einloggen, um Zugang zu erhalten

Abstract

Vaccines have been successful in reducing the mortality and morbidity, but most of them are delivered by intramuscular or intravenous route. They are associated with pain to the baby and bring lot of anxiety for the parents. There has been a marked increase in the number of injections required in first two years of life for completing the vaccination schedule. Hence, there is a need to have a painless vaccine delivery system. Numerous new routes of vaccination like, oral, nasal and transdermal routes are being tried. Oral polio and intranasal influenza have already been a success. Other newer approaches like edible vaccines, nasal sprays, dry powder preparations, jet injectors, microneedles and nanopatches are promising in delivering painless vaccines. Many of them are under clinical trials. These vaccine delivery systems will not only be painless but also cost effective, safe and easy to administer in mass population. They may be devoid of the need of cold chain. Painless delivery system will ensure better compliance to vaccination schedule.
Literatur
2.
Zurück zum Zitat Vashishtha VM, Kumar P. 50 years of immunization in India: progress and future. Indian Pediatr. 2013;50:111–8.CrossRefPubMed Vashishtha VM, Kumar P. 50 years of immunization in India: progress and future. Indian Pediatr. 2013;50:111–8.CrossRefPubMed
5.
Zurück zum Zitat Kennedy A, Basket M, Sheedy K. Vaccine attitudes, concerns, and information sources reported by parents of young children: results from the 2009 HealthStyles survey. Pediatrics. 2011;127:S92–9.CrossRefPubMed Kennedy A, Basket M, Sheedy K. Vaccine attitudes, concerns, and information sources reported by parents of young children: results from the 2009 HealthStyles survey. Pediatrics. 2011;127:S92–9.CrossRefPubMed
6.
Zurück zum Zitat Taddio A, Ipp M, Thivakaran S, et al. Survey of the prevalence of immunization non-compliance due to needle fears in children and adults. Vaccine. 2012;30:4807–12.CrossRefPubMed Taddio A, Ipp M, Thivakaran S, et al. Survey of the prevalence of immunization non-compliance due to needle fears in children and adults. Vaccine. 2012;30:4807–12.CrossRefPubMed
7.
Zurück zum Zitat Taddio A, Appleton M, Bortolussi R, et al. Reducing the pain of childhood vaccination: an evidence-based clinical practice guideline. Can Med Assoc J. 2010;182:E843–55.CrossRef Taddio A, Appleton M, Bortolussi R, et al. Reducing the pain of childhood vaccination: an evidence-based clinical practice guideline. Can Med Assoc J. 2010;182:E843–55.CrossRef
8.
Zurück zum Zitat Halpert C, Meier S, Naus M. Reducing immunization injection pain in infants. BCMJ. 2015;57:189. Halpert C, Meier S, Naus M. Reducing immunization injection pain in infants. BCMJ. 2015;57:189.
9.
Zurück zum Zitat Eden LM, Macintosh JLB, Luthy KE, Beckstrand RL. Minimizing pain during childhood vaccination injections: improving adherence to vaccination schedules. Pediatric Health Med Ther. 2014;5:127–40. Eden LM, Macintosh JLB, Luthy KE, Beckstrand RL. Minimizing pain during childhood vaccination injections: improving adherence to vaccination schedules. Pediatric Health Med Ther. 2014;5:127–40.
10.
Zurück zum Zitat Schechter NL, Zempsky WT, Cohen LL, McGrath PJ, McMurtry CM, Bright NS. Pain reduction during pediatric immunizations: evidence-based review and recommendations. Pediatrics. 2007;119:e1184–98.CrossRefPubMed Schechter NL, Zempsky WT, Cohen LL, McGrath PJ, McMurtry CM, Bright NS. Pain reduction during pediatric immunizations: evidence-based review and recommendations. Pediatrics. 2007;119:e1184–98.CrossRefPubMed
12.
13.
Zurück zum Zitat Jackson BR, Iqbal S, Mahon B; Centers for Disease Control and Prevention (CDC). Updated recommendations for the use of typhoid vaccine--Advisory Committee on Immunization Practices, United States, 2015. MMWR Morb Mortal Wkly Rep. 2015;64:305–8. Jackson BR, Iqbal S, Mahon B; Centers for Disease Control and Prevention (CDC). Updated recommendations for the use of typhoid vaccine--Advisory Committee on Immunization Practices, United States, 2015. MMWR Morb Mortal Wkly Rep. 2015;64:305–8.
14.
Zurück zum Zitat Saha A, Rosewell A, Hayen A, MacIntyre CR, Qadri F. Improving immunization approaches to cholera. Expert Rev Vaccines. 2017;16:235–48.CrossRefPubMed Saha A, Rosewell A, Hayen A, MacIntyre CR, Qadri F. Improving immunization approaches to cholera. Expert Rev Vaccines. 2017;16:235–48.CrossRefPubMed
15.
Zurück zum Zitat Qadri F, Wierzba TF, Ali M, et al. Efficacy of a single-dose, inactivated oral cholera vaccine in Bangladesh. N Engl J Med. 2016;374:1723–32.CrossRefPubMed Qadri F, Wierzba TF, Ali M, et al. Efficacy of a single-dose, inactivated oral cholera vaccine in Bangladesh. N Engl J Med. 2016;374:1723–32.CrossRefPubMed
16.
Zurück zum Zitat Mason HS, Warzecha H, Mor T, Arntzen CJ. Edible plant vaccines: applications for prophylactic and therapeutic molecular medicine. Trends Mol Med. 2002;8:324–9.CrossRefPubMed Mason HS, Warzecha H, Mor T, Arntzen CJ. Edible plant vaccines: applications for prophylactic and therapeutic molecular medicine. Trends Mol Med. 2002;8:324–9.CrossRefPubMed
17.
Zurück zum Zitat Jain A, Saini V, Kohli DV. Edible transgenic plant vaccines for different diseases. Curr Pharm Biotechnol. 2013;14:594–614.CrossRefPubMed Jain A, Saini V, Kohli DV. Edible transgenic plant vaccines for different diseases. Curr Pharm Biotechnol. 2013;14:594–614.CrossRefPubMed
18.
19.
Zurück zum Zitat Lal P, Ramachandran VG, Goyal R, Sharma R. Edible vaccines: current status and future. Indian J Med Microbiol. 2007;25:93–102.CrossRefPubMed Lal P, Ramachandran VG, Goyal R, Sharma R. Edible vaccines: current status and future. Indian J Med Microbiol. 2007;25:93–102.CrossRefPubMed
20.
Zurück zum Zitat Czerkinsky C, Cuburu N, Kweon M-N, Anjuere F, Holmgren J. Sublingual vaccination. Hum Vaccin. 2011;7:110–4.CrossRefPubMed Czerkinsky C, Cuburu N, Kweon M-N, Anjuere F, Holmgren J. Sublingual vaccination. Hum Vaccin. 2011;7:110–4.CrossRefPubMed
21.
Zurück zum Zitat Raghavan S, Östberg AK, Flach C-F, et al. Sublingual immunization protects against Helicobacter pylori infection and induces T and B cell responses in the stomach. Infect Immun. 2010;78:4251–60. Raghavan S, Östberg AK, Flach C-F, et al. Sublingual immunization protects against Helicobacter pylori infection and induces T and B cell responses in the stomach. Infect Immun. 2010;78:4251–60.
22.
Zurück zum Zitat Lee H-J, Cho H, Kim M-G, et al. Sublingual immunization of trivalent human papilloma virus DNA vaccine in baculovirus nanovector for protection against vaginal challenge. PLoS One. 2015;10:e0119408.CrossRefPubMedPubMedCentral Lee H-J, Cho H, Kim M-G, et al. Sublingual immunization of trivalent human papilloma virus DNA vaccine in baculovirus nanovector for protection against vaginal challenge. PLoS One. 2015;10:e0119408.CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Kraan H, Vrieling H, Czerkinsky C, Jiskoot W, Kersten G, Amorij J-P. Buccal and sublingual vaccine delivery. J Control Release. 2014;190:580–92.CrossRefPubMed Kraan H, Vrieling H, Czerkinsky C, Jiskoot W, Kersten G, Amorij J-P. Buccal and sublingual vaccine delivery. J Control Release. 2014;190:580–92.CrossRefPubMed
26.
Zurück zum Zitat Brain JD. Inhalation, deposition, and fate of insulin and other therapeutic proteins. Diabetes Technol Ther. 2007;9:S4–15.CrossRefPubMed Brain JD. Inhalation, deposition, and fate of insulin and other therapeutic proteins. Diabetes Technol Ther. 2007;9:S4–15.CrossRefPubMed
27.
Zurück zum Zitat Birkhoff M, Leitz M, Marx D. Advantages of intranasal vaccination and considerations on device selection. Indian J Pharm Sci. 2009;71:729–31.PubMedCentral Birkhoff M, Leitz M, Marx D. Advantages of intranasal vaccination and considerations on device selection. Indian J Pharm Sci. 2009;71:729–31.PubMedCentral
29.
Zurück zum Zitat Makidon PE, Bielinska AU, Nigavekar SS, et al. Pre-clinical evaluation of a novel nanoemulsion-based hepatitis B mucosal vaccine. PLoS One. 2008;3:e2954.CrossRefPubMedPubMedCentral Makidon PE, Bielinska AU, Nigavekar SS, et al. Pre-clinical evaluation of a novel nanoemulsion-based hepatitis B mucosal vaccine. PLoS One. 2008;3:e2954.CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Suzuki H, Watari A, Hashimoto E, et al. C-Terminal Clostridium perfringens enterotoxin-mediated antigen delivery for nasal pneumococcal vaccine. PLoS One. 2015;10:e0126352. Suzuki H, Watari A, Hashimoto E, et al. C-Terminal Clostridium perfringens enterotoxin-mediated antigen delivery for nasal pneumococcal vaccine. PLoS One. 2015;10:e0126352.
31.
Zurück zum Zitat Nantachit N, Sunintaboon P, Ubol S. Responses of primary human nasal epithelial cells to EDIII-DENV stimulation: the first step to intranasal dengue vaccination. Virol J. 2016;13:142.CrossRefPubMedPubMedCentral Nantachit N, Sunintaboon P, Ubol S. Responses of primary human nasal epithelial cells to EDIII-DENV stimulation: the first step to intranasal dengue vaccination. Virol J. 2016;13:142.CrossRefPubMedPubMedCentral
33.
Zurück zum Zitat Thomas C, Gupta V, Ahsan F. Influence of surface charge of PLGA particles of recombinant hepatitis B surface antigen in enhancing systemic and mucosal immune responses. Int J Pharm. 2009;379:41–50.CrossRefPubMed Thomas C, Gupta V, Ahsan F. Influence of surface charge of PLGA particles of recombinant hepatitis B surface antigen in enhancing systemic and mucosal immune responses. Int J Pharm. 2009;379:41–50.CrossRefPubMed
34.
Zurück zum Zitat Lin W-H, Griffin DE, Rota PA, et al. Successful respiratory immunization with dry powder live-attenuated measles virus vaccine in rhesus macaques. Proc Natl Acad Sci U S A. 2011;108:2987–92.CrossRefPubMedPubMedCentral Lin W-H, Griffin DE, Rota PA, et al. Successful respiratory immunization with dry powder live-attenuated measles virus vaccine in rhesus macaques. Proc Natl Acad Sci U S A. 2011;108:2987–92.CrossRefPubMedPubMedCentral
35.
Zurück zum Zitat Lu D, Garcia-Contreras L, Muttil P, et al. Pulmonary immunization using antigen 85-B polymeric microparticles to boost tuberculosis immunity. AAPS J. 2010;12:338–47.CrossRefPubMedPubMedCentral Lu D, Garcia-Contreras L, Muttil P, et al. Pulmonary immunization using antigen 85-B polymeric microparticles to boost tuberculosis immunity. AAPS J. 2010;12:338–47.CrossRefPubMedPubMedCentral
36.
Zurück zum Zitat Tonnis WF, Lexmond AJ, Frijlink HW, de Boer AH, Hinrichs WLJ. Devices and formulations for pulmonary vaccination. Expert Opin Drug Deliv. 2013;10:1383–97.CrossRefPubMed Tonnis WF, Lexmond AJ, Frijlink HW, de Boer AH, Hinrichs WLJ. Devices and formulations for pulmonary vaccination. Expert Opin Drug Deliv. 2013;10:1383–97.CrossRefPubMed
37.
Zurück zum Zitat Dilraj A, Cutts FT, de Castro JF, et al. Response to different measles vaccine strains given by aerosol and subcutaneous routes to schoolchildren: a randomised trial. Lancet. 2000;355:798–803.CrossRefPubMed Dilraj A, Cutts FT, de Castro JF, et al. Response to different measles vaccine strains given by aerosol and subcutaneous routes to schoolchildren: a randomised trial. Lancet. 2000;355:798–803.CrossRefPubMed
38.
Zurück zum Zitat Bennett JV. Fernandez de Castro J, Valdespino-Gomez JL, et al. Aerosolized measles and measles-rubella vaccines induce better measles antibody booster responses than injected vaccines: randomized trials in Mexican schoolchildren Bull World Health Organ. 2002;80:806–12.PubMed Bennett JV. Fernandez de Castro J, Valdespino-Gomez JL, et al. Aerosolized measles and measles-rubella vaccines induce better measles antibody booster responses than injected vaccines: randomized trials in Mexican schoolchildren Bull World Health Organ. 2002;80:806–12.PubMed
39.
Zurück zum Zitat Feng Z-X, Wei Y-N, Li G-L, et al. Development and validation of an attenuated Mycoplasma hyopneumoniae aerosol vaccine. Vet Microbiol. 2013;167:417–24.CrossRefPubMed Feng Z-X, Wei Y-N, Li G-L, et al. Development and validation of an attenuated Mycoplasma hyopneumoniae aerosol vaccine. Vet Microbiol. 2013;167:417–24.CrossRefPubMed
41.
Zurück zum Zitat McAllister DV, Wang PM, Davis SP, et al. Microfabricated needles for transdermal delivery of macromolecules and nanoparticles: fabrication methods and transport studies. Proc Natl Acad Sci U S A. 2003;100:13755–60.CrossRefPubMedPubMedCentral McAllister DV, Wang PM, Davis SP, et al. Microfabricated needles for transdermal delivery of macromolecules and nanoparticles: fabrication methods and transport studies. Proc Natl Acad Sci U S A. 2003;100:13755–60.CrossRefPubMedPubMedCentral
42.
Zurück zum Zitat Levin Y, Kochba E, Shukarev G, Rusch S, Herrera-Taracena G, van Damme P. A phase 1, open-label, randomized study to compare the immunogenicity and safety of different administration routes and doses of virosomal influenza vaccine in elderly. Vaccine. 2016;34:5262–72.CrossRefPubMed Levin Y, Kochba E, Shukarev G, Rusch S, Herrera-Taracena G, van Damme P. A phase 1, open-label, randomized study to compare the immunogenicity and safety of different administration routes and doses of virosomal influenza vaccine in elderly. Vaccine. 2016;34:5262–72.CrossRefPubMed
43.
Zurück zum Zitat Behrens RH, Cramer JP, Jelinek T, et al. Efficacy and safety of a patch vaccine containing heat-labile toxin from Escherichia coli against travellers’ diarrhoea: a phase 3, randomised, double-blind, placebo-controlled field trial in travellers from Europe to Mexico and Guatemala. Lancet Infect Dis. 2014;14:197–204.CrossRefPubMed Behrens RH, Cramer JP, Jelinek T, et al. Efficacy and safety of a patch vaccine containing heat-labile toxin from Escherichia coli against travellers’ diarrhoea: a phase 3, randomised, double-blind, placebo-controlled field trial in travellers from Europe to Mexico and Guatemala. Lancet Infect Dis. 2014;14:197–204.CrossRefPubMed
44.
Zurück zum Zitat Prow TW, Chen X, Prow NA, et al. Nanopatch-targeted skin vaccination against West Nile Virus and Chikungunya virus in mice. Small Weinh Bergstr Ger. 2010;6:1776–84. Prow TW, Chen X, Prow NA, et al. Nanopatch-targeted skin vaccination against West Nile Virus and Chikungunya virus in mice. Small Weinh Bergstr Ger. 2010;6:1776–84.
45.
Zurück zum Zitat Fernando GJP, Chen X, Primiero CA, et al. Nanopatch targeted delivery of both antigen and adjuvant to skin synergistically drives enhanced antibody responses. J Control Release. 2012;159:215–21.CrossRefPubMed Fernando GJP, Chen X, Primiero CA, et al. Nanopatch targeted delivery of both antigen and adjuvant to skin synergistically drives enhanced antibody responses. J Control Release. 2012;159:215–21.CrossRefPubMed
47.
Zurück zum Zitat Kim Y-C, Prausnitz MR. Enabling skin vaccination using new delivery technologies. Curr Top Microbiol Immunol. 2012;351:77–112.PubMedPubMedCentral Kim Y-C, Prausnitz MR. Enabling skin vaccination using new delivery technologies. Curr Top Microbiol Immunol. 2012;351:77–112.PubMedPubMedCentral
Metadaten
Titel
Advances Towards Painless Vaccination and Newer Modes of Vaccine Delivery
verfasst von
Neha Garg
Anju Aggarwal
Publikationsdatum
16.06.2017
Verlag
Springer India
Erschienen in
Indian Journal of Pediatrics / Ausgabe 2/2018
Print ISSN: 0019-5456
Elektronische ISSN: 0973-7693
DOI
https://doi.org/10.1007/s12098-017-2377-2

Weitere Artikel der Ausgabe 2/2018

Indian Journal of Pediatrics 2/2018 Zur Ausgabe

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.